SEC Form 4 · accession 0001209191-16-112536
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George P Hampton
Officer — See remarks
Period of report
Apr 1, 2016
Accepted (ET)
Apr 4, 2016 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Apr 1, 2016 | M | 7,000 | — | A | 8,092 | D | |
| Ordinary Shares | Apr 1, 2016 | F | 1,915 | $17.37 | D | 6,177 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Apr 1, 2016 | M | 7,000 | D | — | — | Ordinary Shares | 7,000 | 21,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 1,092 ordinary shares of the Issuer acquired by the reporting person on December 1, 2015 pursuant to an employee stock purchase program.
- F3On April 1, 2015 and May 1, 2015, the reporting person was granted an aggregate of 28,000 restricted stock units. The restricted stock units vest in four equal annual installments beginning on the April 1, 2016.
Remarks
The Reporting Person is EVP, Global Orphan Business Unit and International Operations of the Issuer.